Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Protagonist Therapeutics
Biotech
J&J, Protagonist's oral psoriasis prospect scores in phase 3s
The phase 3 successes pad the IL-23 blocker's case as J&J prepares to prove its worth against BMS' oral psoriasis treatment Sotyktu.
Zoey Becker
Nov 19, 2024 11:44am
Takeda plays Protagonist, paying $300M for blood disease pact
Jan 31, 2024 5:41pm
Protagonist, J&J oral psoriasis efficacy data spur phase 3 plans
Jul 4, 2023 2:50am
J&J props up immunology, oncology franchises after R&D overhaul
Apr 18, 2023 11:05am
Protagonist's story turns for the better on psoriasis data
Mar 7, 2023 10:45am
Drugs up for sale, on the shelf in biotech pipeline clear-outs
Nov 9, 2022 9:40am
